The Journal du Médecin awards each year the Prix Galien named after the famous physician of Greco-Roman antiquity considered to be the father of Western medicine. A jury made up of pharmacologists from all Belgian universities chose the vaccine developed by Pfizer from among fourteen participating drugs. The jury praised the rapid development of the mRNA vaccine, which took place in less than a year “building on the pioneering work of the past decade”.
The Prix Galien for the medical device that can improve a treatment rewarded Granulox, a spray used in the treatment of complex, multifactorial and difficult to heal wounds.
Finally, the 2020 Galien Prize for clinical and / or fundamental pharmacology was awarded to Mireille Alhouayek of the Louvain Drug Research Institute (UCLouvain) for her research on endocannabinoids, cannabinoids that the human body produces itself.